Guo Zhenyu: New Medical drugs retail sales in the long-term positive change – he
New medical reform Implemented, pharmacies will be in the high-end passenger-based, strong purchasing power and brand awareness and brand OTC pharmacy to become a common enterprise customers. Retail pharmacy lies in the implementation of transformation must take the road of diversified development, while strengthening corporate and brand OTC Cooperation And strategic cooperation of both sides will return and bring branded passenger traffic and business opportunities. However, OTC brand building, need to invest enormous human and financial resources must also ensure that the brand product quality and efficacy of the security and stability
This year's two sessions on the new health care reform remains a hot topic. Data show that in the next three years, the state will invest 850 billion yuan in new medical reform, the people's health care burdens, solve the "medical treatment is difficult, expensive medicine" issue. CPPCC National Committee member, Health Minister Chen Zhu has said that the recent new medical reform five tasks have been implemented, such as the first task be the former residents are protected, and the second is the basic drugs, and the third is to improve primary health care institutions, the fourth a public health, the fifth is the public hospital reform.
"New medical reform is brought about both challenges and opportunities, but the opportunities will outweigh the challenges." Vice president of China Nonprescription Medicines Association, World Self-Medication Industry Association, chairman of Yunnan Dian Hong Guo Zhenyu told reporters Pharmaceutical interview that, looking back now the whole Drugs Market is a bit distorted inverted triangle, the hospital occupied the entire pharmaceutical sales market share of 70% -80%, only 20% of the grass-roots community pharmacies. High-end market tertiary hospitals, secondary hospitals are in the end, pharmacies, community and rural health clinic is the smallest market in the allocation of resources is not balanced. Guo Zhenyu said: "If implemented by the new spirit of universal health care reform Health Insurance Later, the pyramid will be the other way round: a minor illness into the pharmacy, communities, the disease to two hospitals, small clinics, serious illness only to the tertiary hospitals. By then, the community and NCMS Will become a solid tower base and the largest market. "
"The new medical reform will facilitate industry usher in era of shuffle." According to Guo Zhenyu description, GMP, China has 4,700 pharmaceutical, 13000 Medicine Commercial companies, 360 000 pharmacies, 550 000 rural health care clinics. Small, scattered, chaotic, poor status of the industry led to confusion. The new medical reform, no brand company will be reorganized or eliminated, there is no qualified distribution business, poor product quality, after-sales service is poor, do not understand the market Marketing The enterprises will be eliminated. Industry concentration and self-discipline will increase as well.
"For the pharmaceutical retail industry, the challenges of the new health care reform is the first implementation of essential drugs Community The impact of zero difference, taking a large number of passenger flow at the same time as the most promising competitor retail pharmacies. People credit card to use basic drugs, Advertisement Effect will be reduced to low. "Guo Zhenyu analysis, China's pharmaceutical customers mainly influenced by advertising and pharmacy staff recommend that this guidance be subverted if the retail market model will change, and new medical reform is precisely to provide the conditions for change.
HC pharmaceutical industry network "Retail pharmacy lies in the implementation of transformation must take the road of diversified development, while strengthening cooperation with the brand OTC business." Guo Zhenyu that after the implementation of the new medical reform, drug stores and high-end will be the main passenger flow, strong purchasing power and brand consciousness, making it the brand OTC pharmacy and the common enterprise customers. The strategic cooperation between the two sides will return and bring branded passenger traffic and business opportunities. However, OTC brand building, need to invest enormous human and financial resources must also ensure that the brand product quality and efficacy of the security and stability.
Related survey data show that up to 75% of the consumers attention in pharmacy buy branded products. "Brand can be used as an array of drugs to consumers when judging means. OTC companies want their brands to enter the consumer to buy memory and attention, we must do everything possible to make products." Guo Zhenyu told reporters, retail pharmacies and the community have different positioning, it is a window to provide services to self-medication, pharmacy professional pharmacy services through joint industrial consumers self-medication and medication safety knowledge and education to get the trust of patients and therefore get their own living space. Therefore, OTC companies and retail pharmacies to carry out such as: common OTC drugs to enhance publicity to consumers using a variety of ways to self-medication and medication safety knowledge, in the training manager, pharmacist, etc..
"New health care reform on the pharmaceutical retail industry is bad in terms of short-term and long-term is positive." Guo Zhenyu believes that the new medical reform advocate self-care prevention, small patient self-medication, OTC business and is conducive to the development of retail pharmacies. In the dead "disease" rule "disease" of the Chinese health concept, consumers increasingly accept and learn self-medication, the patient from passive to active participants. The health needs and improve the level of self-medication will drive the retail terminal and OTC pharmaceutical business development.
We are high quality suppliers, our products such as Disposable Tooth Scaler , Disposable Cervical Sampler for oversee buyer. To know more, please visits disposable medical exporter.